VCEL Vericel Dashboard

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Company profile

Ticker

VCEL

Exchange

NASDAQ

Website

vcel.com/

CEO

Dominick Colangelo

Incorporated

Michigan

Location

Massachusetts

Fiscal year end

Dec 31

Sector

Manufacturing > Biological Product (except Diagnostic) Manufacturing

Industry (SIC)

Biological Products, (No Diagnostic Substances)

AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Enzon Pharmaceuticals • Denali Therapeutics • Allogene Therapeutics ...

Former names

AASTROM BIOSCIENCES INC

SEC CIK

0000887359

Corporate docs

Articles of Incorporation & Bylaws

IRS number

943096597

VCEL stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

9 Apr 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8)

Stocks That Hit 52-Week Highs On Thursday

8 Apr 21

Thursday morning saw 168 companies set new 52-week highs.

The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs

19 Mar 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18)

50 Biggest Movers From Yesterday

19 Mar 21

12 Health Care Stocks Moving In Thursday's Intraday Session

18 Mar 21

Press releases

Pro users get this 30m faster

Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021

9 Apr 21

CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo,

Vericel Set to Join S&P SmallCap 600

17 Mar 21

NEW YORK, March 17, 2021 /PRNewswire/ -- Vericel Corp. (NASD:VCEL) will replace QEP Resources Inc. (NYSE:QEP) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, March 22. S&P 500

Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021

10 Mar 21

CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo,

Vericel Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Full-Year 2021 Financial Guidance

24 Feb 21

Vericel Corp. to Host Earnings Call

24 Feb 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

24 Feb 21

17 Apr 21

31 Dec 21

Financial summary

Financial statements Chart VCEL financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Vericel earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	33.83M	33.83M	33.83M	33.83M	33.83M	33.83M
Cash burn (monthly)	3.3M	(positive/no burn)	(positive/no burn)	(positive/no burn)	(positive/no burn)	(positive/no burn)
Cash used (since last report)	11.75M	n/a	n/a	n/a	n/a	n/a
Cash remaining	22.08M	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	6.7	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

VCEL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 Mar 21	Joseph Anthony Mara Jr	Common Stock	Payment of exercise	Dispose F	No	No	55.55	1,178	65.44K	2,822
31 Mar 21	Joseph Anthony Mara Jr	Common Stock	Option exercise	Aquire M	No	No	0	4,000	0	4,000
31 Mar 21	Joseph Anthony Mara Jr	RSU Common Stock	Option exercise	Dispose M	No	No	55.55	4,000	222.2K	12,000
30 Mar 21	Jonathan Mark Hopper	Common Stock	Sell	Dispose S	No	Yes	51.8412	11,104	575.64K	38,480
30 Mar 21	Jonathan Mark Hopper	Common Stock	Option exercise	Aquire M	No	No	10.95	20,000	219K	49,584
30 Mar 21	Jonathan Mark Hopper	Common Stock	Sell	Dispose S	No	Yes	51	1,820	92.82K	29,584
30 Mar 21	Jonathan Mark Hopper	Common Stock	Option exercise	Aquire M	No	No	10.95	8,438	92.4K	31,404
30 Mar 21	Jonathan Mark Hopper	Common Stock	Sell	Dispose S	No	Yes	50.561	5,000	252.81K	22,966
30 Mar 21	Jonathan Mark Hopper	Common Stock	Option exercise	Aquire M	No	No	10.95	5,000	54.75K	27,966
30 Mar 21	Jonathan Mark Hopper	Stock Option Common Stock	Option exercise	Dispose M	No	No	10.95	8,438	92.4K	58,298

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

VCEL institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

98.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	166	136	+22.1%
Opened positions	43	22	+95.5%
Closed positions	13	19	-31.6%
Increased positions	50	41	+22.0%
Reduced positions	56	52	+7.7%

13F shares	Current	Prev Q	Change
Total value	2.06B	979.53M	+110.6%
Total shares	45.42M	42.26M	+7.5%
Total puts	46.7K	51K	-8.4%
Total calls	55.2K	130.2K	-57.6%
Total put/call ratio	0.8	0.4	+116.0%

Largest owners	Shares	Value	Change
RTW Investments	4.52M	$139.5M	+17.3%
Brown Capital Management	4.02M	$124.22M	+2.9%
BLK Blackrock	3.29M	$101.71M	+7.2%
WDR Waddell & Reed Financial	2.77M	$85.5M	-0.2%
Vanguard	2.33M	$72.05M	+1.1%
STT State Street	2.19M	$67.51M	+7.9%
FHI Federated Hermes	1.37M	$42.38M	+3.6%
Next Century Growth Investors	1.37M	$42.32M	+8.3%
WFC Wells Fargo & Co.	1.21M	$37.39M	-1.5%
Kopp Family Office	1.15M	$35.54M	0.0%

Largest transactions	Shares	Bought/sold	Change
Deerfield Management	64.95K	-1.43M	-95.6%
BNP Paribas Asset Management Holding	996.54K	+996.54K	NEW
UBS UBS Group AG - Registered Shares	918.21K	+907.55K	+8512.0%
RTW Investments	4.52M	+666.72K	+17.3%
Great Point Partners	900K	-580.79K	-39.2%
Artisan Partners Limited Partnership	514.64K	+514.64K	NEW
FMR	487.88K	+487.34K	+90752.7%
Kent Lake Capital	370K	+370K	NEW
Marshall Wace	0	-286.43K	EXIT
Silverarc Capital Management	281.35K	+281.35K	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

ThermoGenesis • BioCardia • Athersys • Ocugen • Cellular Biomedicine • Regenicin • MyoKardia • Biostage • AVITA Medical

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absenteeism, Academy, Accident, aimed, airline, Aldisert, ancestry, Army, Artillery, ascertain, attained, Biden, Bingham, Biogen, biotech, bromelain, carryforward, characteristic, Chondral, choose, circumstance, clerking, College, color, commandeer, commandeered, comparison, contact, contractor, ConvaTec, convene, coordination, counsel, courier, COVID, creed, Cybersecurity, cycle, daily, Defense, depression, disability, discretionary, discriminate, distancing, divided, downturn, Dr, earned, ease, economy, Edinburgh, eleven, enriched, exaggerate, explicitly, fallen, Fellow, Ferring, Fidelity, fit, fluidity, Flynn, formatted, fringe, gender, genetic, geographic, geographical, geography, graduated, ground, guide, half, heightened, heightening, home, Honorable, Hopper, hygiene, implicitly, incentivizing, indirect, infection, inline, inoculate, Interactive, irrecoverable, janitorial, job, Jonathan, joseph, Keele, lessor, light, lockdown, Machinery, macroeconomic, mara, marital, markedly, McCutchen, mental, motivating, move, moved, Nephew, Northwestern, orientation, outbreak, outset, oversee, overseen, overturned, Page, pandemic, paused, PDUFA, PEAK, peer, penetration, pennell, picked, pipeline, pooling, postpone, postponed, prioritization, prosecutor, proteolytic, proud, race, reevaluate, reinstituted, remotely, rescheduled, resurgence, reward, risen, rolling, ROU, Royal, Ruggero, sandra, sanitary, Sean, sector, sex, sexual, situation, Sloan, slowdown, Smith, software, sought, strain, Stryker, surge, telemedicine, Thomson, threatened, tied, timeline, traditional, travel, unemployment, unwilling, USA, vehicle, Verastem, verification, verify, Vermont, veteran, violative, virtual, West, widespread, withheld, workplace, worsening, Wuhan

Removed: achievement, acquiring, Allen, allocated, Allosource, anonyme, Asia, automated, Biodel, Biology, block, Booz, cancer, cardiomyopathy, cDNA, centralized, CEO, CFO, coercive, congressional, considerable, Daniel, Danish, DCM, decision, Delisting, demanding, dilated, disclosing, discourage, DNA, Dohmen, double, excluded, executing, exploit, flexibility, Formulating, French, functional, funded, fundraising, genomic, Geology, Hamilton, heart, identification, inventive, Korea, Lederle, lender, Mayo, memorandum, Microbiology, monetization, multicellular, mutually, Myriad, natural, negotiated, notice, NPS, occurred, operated, optimizing, Orlando, oversaw, patented, phenomena, prompt, qualify, reciting, Rejection, remeasured, repatriated, rest, Rochester, role, SBIR, scalable, shared, Simon, Singapore, South, staying, syndicated, takeover, taxation, territorial, territory, Trump, unpatentable, VA, vast, Vital, voucher, weighted, widely, withholding, Wyeth

From filing 10-K 2020 FY